Thursday November 26 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

G2 Phase

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Recent Publications on G2 Phase:

Pubmed Logo
The induction of cytotoxicity, oxidative stress, and genotoxicity by root canal sealers in mammalian cells.
OBJECTIVE: Toxicologic aspects of the root canal sealers Acroseal,...
17th November, 2009
Departament of Restorative Dentistry and Endodontics, Sao Paulo State Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009 Dec;108(6):952-60.
DOI Direct Link
Cohesin promotes the repair of ionizing radiation-induced DNA double-strand breaks in replicated chromatin.
The cohesin protein complex holds sister chromatids together after...
13th November, 2009
Gray Institute for Radiation Oncology and Biology, University of Oxford, Nucleic Acids Res. 2009 Nov 11.
DOI Direct Link
The polyembryonic wasp Copidosoma floridanum produces two castes by differentially parceling the germ line to daughter embryos during embryo proliferation.
Eggs of the polyembryonic wasp Copidosoma floridanum undergo a clonal...
12th November, 2009
Department of Entomology, University of Georgia, Athens, GA, 30605, USA. Dev Genes Evol. 2009 Nov 11.
DOI Direct Link
Large T antigen promotes JC virus replication in G2-arrested cells by inducing ATM- and ATR-mediated G2 checkpoint signaling.
Large T antigen (TAg) of the human polyomavirus JC virus (JCV) possesses...
12th November, 2009
Hokkaido University, Japan; J Biol Chem. 2009 Nov 10.
DOI Direct Link
Recognition of O6MeG lesions by MGMT and mismatch repair proficiency may be a prerequisite for low-dose radiation hypersensitivity.
Low-dose hyper-radiosensitivity (HRS) is the phenomenon whereby cells...
6th November, 2009
Division of Radiation Therapy, Trinity College Dublin, Dublin, Ireland. Radiat Res. 2009 Oct;172(4):405-13.
DOI Direct Link

View more research publications.

Press Releases About G2 Phase:

BioPortfolio Logo
Pharmasset Reports Fiscal Year End 2009 Financial Results 25th November, 2009 Pharmasset, Inc.
PRINCETON, N.J., Nov. 25 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (Nasdaq: VRUS), a clinical stage pharmaceutical company committed to discovering, developing and commercializing novel drugs to
Onyx Pharmaceuticals Announces December 2009 Investor Events 25th November, 2009 Onyx Pharmaceuticals, Inc.
EMERYVILLE, Calif., Nov. 25 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that the company will host two investor events in December: ASH Briefing December 7,
The Lupus Foundation of America Hosts Special Webinar to Discuss BENLYSTA(TM) Results 25th November, 2009 Lupus Foundation of America
WHAT: The Lupus Foundation of America (LFA) invites those living with lupus to a special Webinar with LFA's Medical Director, Dr. Joan Merrill. Human Genome Sciences (HGSI) and GlaxoSmithKline
Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 25th November, 2009 Ardea Biosciences, Inc.
SAN DIEGO, Nov. 25 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc. (Nasdaq: RDEA) announced today that Barry D. Quart, Pharm.D., president and chief executive officer, will present at the Piper
Reportlinker Adds Wound Care Products - A World Market Analysis 25th November, 2009 Reportlinker
NEW YORK, Nov. 25 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Wound Care Products - A World Market Analysis http://www.reportlinker.com

BioNews Results for G2 Phase:

RSS Logo
BioPortfolio Logo
Sunesis to Present Nonclinical Voreloxin Combination Data at AACR-EORTC-NCI Conference
Pharma Live:  Nov 11 2009 4:48AM Matching: g2 phase
Sunesis Pharmaceuticals, Inc. (SNSS) to Present Nonclinical Voreloxin Combination Data at AACR-EORTC-NCI Confe
BioSpace:  Nov 10 2009 6:47PM Matching: g2 phase
Sunesis' Voreloxin Receives FDA Orphan Drug Designation For Acute Myeloid Leukemia
Medical News Today:  Nov 6 2009 12:12PM Matching: g2 phase
Sunesis' Voreloxin Receives FDA Orphan Drug Designation for Acute Myeloid Leukemia
Pharma Live:  Nov 5 2009 9:54PM Matching: g2 phase
Sunesis' Voreloxin Receives FDA Orphan Drug Designation for Acute Myeloid Leukemia
PR Newswire via Yahoo!:  Nov 5 2009 2:14PM Matching: g2 phase
Promote your company here: BioNewsCast - Press Release Distribution

View more news.

G2 Phase Patents:

USPTO Logo
US Patent No.Title
7485460 Enhanced growth of adult stem cells with Dkk-1
7517902 Substituted indazoles, compositions containing the same, and the preparation and use thereof
7517986 Tetrahydropyridothiophenes for use in the treatment of cancer
7521071 Formulation of oral compositions comprising arsenic trioxide and methods of use thereof
7521457 Pyrimidines as PLK inhibitors

View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for G2 Phase scientists - we have details of around 499 individuals working on G2 Phase .


This page has been viewed 375 times
Recent Search Terms used to find this page: G2 phase | G2 phase | G2 phase description | g2 phase | G2 phase description | g2 phase | g2 phase images | G2 phase | G2 phase image | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for G2 Phase across BioPortfolio, or for G2 Phase Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.